Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MGRX/Capital expenditures

Mangoceuticals, Inc. (MGRX) Capital expenditures 2023–2024

Mangoceuticals, Inc. (MGRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$3,519FY2024 · since FY2023: $43,102 → $3,519
2324
Fiscal yearValueYoY
FY2024$3,519-91.8%
FY2023$43,102—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More MGRX financial trends

MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating marginMGRX Operating cash flowMGRX Free cash flowMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX Shareholders’ equityMGRX overview →